About The ASCO Post
Rights and Permissions
In the Clinic
View By Issue
Pan Pacific Lymphoma Conference 2018
In My Opinion
2018 ASCO Annual Meeting
23rd Congress of EHA
Methotrexate–Induced Kidney Injury
2016 NCCN Annual Conference
Today In Oncology
FDA Approves Pembrolizumab in Combination With Chemotherapy for First-Line Treatment of Metastatic Nonsquamous NSCLC
FDA Updates Prescribing Information for Pembrolizumab and Atezolizumab in Urothelial Carcinoma
Impact of Doctor-Patient Communication on Outcomes in Cancer Survivors
Cetuximab With Radiotherapy Found to Be Inferior to Standard Treatment in HPV-Positive Oropharyngeal Cancer
Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide in Pediatric Intermediate-Risk Rhabdomyosarcoma
Most Read Stories
Fusions and Metastasis in Estrogen Receptor–Positive Breast Cancer
Prognostic Model for Treatment Outcomes in
V600–Mutated Metastatic Melanoma
A Gleason 6 Tumor: Is It Cancer, and Should It Be Treated?
FDA Grants Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis
Abiraterone or Enzalutamide for Newly Diagnosed Metastatic Castrate-Resistant Prostate Cancer?
Most Viewed Videos
Jonathan W. Friedberg, MD, on Follicular Lymphoma: Novel Combination Therapies
Julie M. Vose, MD, MBA, and David G. Maloney, MD, PhD, on NHL: Update on CAR T-Cell Therapies
Bruce D. Cheson, MD, and Richard I. Fisher, MD, on Lymphoma: Treatment Considerations
Jed A. Katzel, MD, on Head and Neck Cancer: Findings on Treatment of Female Patients
Sumanta K. Pal, MD, and Neeraj Agarwal, MD, on Prostate Cancer: The Talapro-2 Trial
© 2018 HSP News Service, L.L.C.
to learn more.